NCT Number: NCT00462410
Effect of Advertisements on Treatment Compliance in Women With Breast Cancer
RATIONALE: Measuring how advertising affects treatment compliance in women with breast cancer may help doctors plan the best treatment.
PURPOSE: This clinical trial is studying how advertisements affect treatment compliance in women with breast cancer.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
About this study
OBJECTIVES:
Primary
- Evaluate the consequences of advertisement on treatment compliance in women with breast cancer.
Secondary
- Determine the factors favoring or not favoring adherence to the medical recommendations.
OUTLINE: Patients and their medical and nonmedical caregivers are interviewed by a sociologist or anthropologist twice over 1 year. The first interview is at the consultation visit and the second interview is at the patient's home. The impact of advertisement on treatment compliance is measured.
PROJECTED ACCRUAL: A total of 65 patients will be accrued for this study.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Diagnosis of breast cancer
- Hormone receptor status not specified
PATIENT CHARACTERISTICS:
- Female
- Menopausal status not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Treatment and study plan
psychosocial assessment and care
ProcedurePrimary outcomes
-
Treatment compliance
Secondary outcomes
-
Factors affecting adherence to the medical plan
Sponsors and collaborators
Lead sponsor
Institut Bergonié
Other
Registry information
Official study title
Socio-anthropological Study Evaluating the Impact of Observance or Treatment in Patients With Breast Cancer
Important dates
- Study start
- 2006
- Primary completion
- 2011
- First posted
- Apr 19, 2007
- Registry last updated
- Jan 23, 2012
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Tumor-Derived FGF19
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsAfrican Cancer Genome: GMD
NCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial Details24GUT540 : Meeting of Breast Cancer Patients and Pathologists
NCT07040514
Breast Cancer, Breast Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNeoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer
NCT06604858
Breast Cancer, Breast Diseases
A Coruña, Spain
View Trial Details